Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Mylan's Fulphila Sets Up The US Market For The Next Biosimilar Showdown

Jul 12 2018

• By Jessica Merrill

CANONSBURG, PENNSYLVANIA, USA - AUGUST 17: Exterior of Mylan Global Headquarters on August 17, 2017 in Canonsburg, PA. Mylan is in the news over pricing of the Epipen.

Additional Topics

Biosimilars Launches Pricing Strategies Commercial BioPharmaceutical

More from New Products

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window